| Biotechnology Industry | Healthcare Sector | Mr. Bret T. Barnhizer CEO | OTC PINK Exchange | 630076107 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
NanoLogix, Inc. is a pioneering biotechnology company that stands at the forefront of live cell and rapid diagnostics, specifically designed for the detection of viable bacteria and other microorganisms. With a strong presence in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing fields, the company offers a suite of products that cater to a wide array of applications. Positioned in Hubbard, Ohio, NanoLogix extends its market reach by supplying its innovative solutions to a diverse collection of medical and scientific entities, including but not limited to laboratories, medical institutions, universities, corporate enterprises, and research establishments. This elaborate network underscores NanoLogix's commitment to advancing microbial detection and analysis, reinforcing its role as a key player in the biotechnology sector.
NanoLogix, Inc. introduces a dynamic range of products aimed at revolutionizing the approach towards microbial detection and cultivation:
Together, these products underscore NanoLogix's dedication to providing comprehensive solutions that address the complex needs of microbial detection and cultivation across multiple sectors, including healthcare, biosecurity, pharmaceuticals, and environmental management, among others.